iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
63 hedge funds and large institutions have $65.5M invested in iShares Genomics Immunology and Healthcare ETF in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.04% less ownership
Funds ownership: 19.62% → 19.58% (-0.04%)
Holders
63
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.56M | |
| 2 | +$2.34M | |
| 3 | +$2.04M | |
| 4 |
Jane Street
New York
|
+$1.55M |
| 5 |
WAP
Wealthcare Advisory Partners
West Chester,
Pennsylvania
|
+$1.4M |
Top Sellers
| 1 | -$15M | |
| 2 | -$934K | |
| 3 | -$720K | |
| 4 |
JWCA
J.W. Cole Advisors
Tampa,
Florida
|
-$265K |
| 5 |
RCS
Retirement Capital Strategies
San Jose,
California
|
-$67.5K |